StonvexLoading…
StonvexStonvexStonvexCore line items from CCJ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | C$3.48B | C$3.14B | C$2.59B | C$1.87B |
Operating Income | C$618.14M | C$510.11M | C$282.86M | C$15.05M |
Net Income | C$589.54M | C$171.84M | C$360.82M | C$89.26M |
EPS (Diluted) | C$1.35 | C$0.39 | C$0.83 | C$0.22 |
Total Assets | C$10.30B | C$9.91B | C$9.93B | C$8.63B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | C$1.11B | C$600.46M | C$566.81M | C$1.14B |
Free Cash Flow OCF − CapEx | C$1.08B | C$693.65M | C$534.50M | C$161.16M |
Shares Outstanding | 435.46M | 435.31M | 434.18M | 432.52M |